brimonidine ophthalmic vs clonidine
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of brimonidine ophthalmic and clonidine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
( 7.2 ) Tricyclic antidepressants may potentially blunt the hypotensive effect of systemic clonidine. 7.3 Tricyclic Antidepressants Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.
Alphagan P
Catapres
Alphagan P eye drops help lower pressure in the eye. It is used for people with open-angle glaucoma or ocular hypertension.
Clonidine (Catapres) is a medicine used to treat high blood pressure. It can be used alone or with other blood pressure medicines.
Alphagan P eye drops are used to lower high pressure inside your eye. This medicine is for people who have open-angle glaucoma or ocular hypertension. Glaucoma can damage the optic nerve and cause vision loss. Ocular hypertension means you have high pressure in the eye, which can lead to glaucoma.
Clonidine is used to treat high blood pressure. High blood pressure can lead to heart disease, stroke, and kidney problems. This medicine helps to lower your blood pressure to a safer level.
Alphagan P is an alpha-2 adrenergic agonist. It works by decreasing the amount of fluid your eye makes. It also helps increase the amount of fluid that drains from your eye, which lowers eye pressure.
Clonidine works in the brain to lower blood pressure. It tells your blood vessels to relax and widen. This makes it easier for blood to flow through your body, which lowers blood pressure.
- • Allergic conjunctivitis (eye allergy)
- • Eye redness
- • Eye itching
- • Burning sensation in the eye
- • Small bumps on the conjunctiva (conjunctival folliculosis)
- • Dry mouth (occurs in about 40 out of 100 people)
- • Drowsiness (occurs in about 33 out of 100 people)
- • Dizziness (occurs in about 16 out of 100 people)
- • Constipation (occurs in about 10 out of 100 people)
- • Feeling sleepy or sedated (occurs in about 10 out of 100 people)
No adverse event reports.
- Pain 3,038
- Fatigue 2,925
- Nausea 2,920
- Headache 2,798
- Hypertension 2,595
Alphagan P may worsen problems caused by poor blood flow. Use caution if you have depression, problems with blood flow to your brain or heart, Raynaud’s phenomenon, low blood pressure when standing up, or thromboangiitis obliterans. Do not touch the tip of the container to your eye or any other surface. This can cause the solution to become contaminated and lead to serious eye damage and vision loss.
If you suddenly stop taking clonidine, your blood pressure may increase. This can cause serious problems. Talk to your doctor before stopping this medicine.
It is not known if Alphagan P will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. It is not known if Alphagan P passes into breast milk. Talk to your doctor before breastfeeding.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if clonidine will harm your unborn baby. Talk to your doctor if you are breastfeeding.
Also Compare, Nearby Drugs
Compare clonidine with
How to Read This brimonidine ophthalmic vs clonidine Comparison
brimonidine ophthalmic is classified in the Alpha-2 Agonist (Ophthalmic) drug class, while clonidine sits within the Central Alpha-2 Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, brimonidine ophthalmic has 0 submissions while clonidine has 14,276. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to both medications work in a similar way to lower blood pressure, which may cause an additive effect when used together.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for brimonidine ophthalmic or clonidine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.